NCT03601689 is a clinical trial of rectal resection in Rectal Neoplasms, sponsored by Moroccan Society of Surgery.

Who is sponsoring NCT03601689?

NCT03601689 is sponsored by Moroccan Society of Surgery.

What drugs are being tested in NCT03601689?

Interventions in NCT03601689: rectal resection.

What condition does NCT03601689 study?

NCT03601689 studies Rectal Neoplasms.

Is NCT03601689 still recruiting?

NCT03601689 is currently completed. Last updated 26 July 2018.

Last reviewed 2018-07-26 · How we verify

NCT03601689

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Completed Last updated 26 July 2018

What this trial tests

trial testing rectal resection in Rectal Neoplasms in 84 participants. Completed in 31 March 2016.

Timeline

1 January 2005

Primary endpoint
31 December 2013

31 March 2016

Quick facts

Lead sponsor	Moroccan Society of Surgery
Status	Completed
Study type	OBSERVATIONAL
Enrollment	84
Start date	1 January 2005
Primary completion	31 December 2013
Estimated completion	31 March 2016
Sites	8 locations across Morocco, Algeria

Drugs / interventions tested

rectal resection

Conditions studied

Rectal Neoplasms — all drugs for Rectal Neoplasms →

Sponsor

Moroccan Society of Surgery

Who can join

18 and older, any sex, with Rectal Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many data suggest that patients with low rectal adenocarcinoma who achieved ypT0N0 status have improved survival and disease-free survival (DFS) compared to all other stages however only few data are available regarding the specific prognosis factors of this subgroup. This retrospective multicentric study aimed to predict the prognosis of patients with complete pathological response after neoadjuvant treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series.
Souadka A, Majbar MA, Benkabbou A, Serji B, et al · · 2019 · cited 5× · PMID 31660903 · DOI 10.1186/s12885-019-6239-3

Verify or expand the search:

Other trials of rectal resection

Trials testing the same drug.

NCT04915326 — IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment · unknown

Other recruiting trials for Rectal Neoplasms

Currently open trials in the same condition.

NCT07522294 — Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision · NA · active not recruiting
NCT07154173 — Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer · recruiting
NCT06442215 — Selection of Surgical Technique in Rectal Cancer · recruiting
NCT06017583 — Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer · Phase 3 · recruiting
NCT05943444 — Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer · NA · recruiting

Other Moroccan Society of Surgery trials

Trials by the same sponsor.

NCT04607577 — Cross-cultural Adaptation and Validation in Moroccan Arabic Dialect "Darija" of the QoR-15 Postoperative Recovery Qualit · unknown
NCT05494281 — Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer · NA · unknown
NCT04130568 — Translation and Adaptation of Learning Organisation Survey for French Speaking Countries · completed
NCT04000802 — Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers · completed
NCT05286411 — Evaluation of the Implementation of a Quality Improvement Program Through Morbidity and Mortality Reviews · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03601689 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Moroccan Society of Surgery
Last refreshed: 26 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03601689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing